Skip to content

Clinical trials

Completed Myeloproliferative Disorders trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Status: Completed Country / region: Canada Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20073
20091
20112
20121
20132
20143
20151
20171
20191
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Children's Oncology Group3
Incyte Corporation3
Alliance for Clinical Trials in Oncology1
Constellation Pharmaceuticals1
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS1
Icahn School of Medicine at Mount Sinai1
John Mascarenhas1
Medical College of Wisconsin1
NCIC Clinical Trials Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders23
Primary Myelofibrosis12
Leukemia7
Polycythemia Vera7
Hematologic Diseases6
Myelodysplastic Syndromes6
Thrombocythemia, Essential6
Bone Marrow Diseases5
Leukemia, Myelomonocytic, Chronic5
Leukemia, Myeloid, Acute4

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.